Age changes the clinical question
For an older adult, the question is not simply whether cannabis can affect pain or sleep. Existing illness, balance, cognition and several concurrent medicines can change the practical consequences. Health Canada notes that adults over 55 may be more sensitive to cannabis and more vulnerable to adverse effects, especially with relevant medical conditions.
Benefits need condition-specific evidence
Some cannabinoid treatments have evidence for particular symptoms, but that does not establish a general anti-aging effect. Laboratory interest in neuroprotection is not proof that cannabis prevents or slows dementia. Likewise, a report that patients reduced another medicine cannot show that stopping that treatment is safe or that cannabis caused the improvement.
Interactions and daily function
Drowsiness, dizziness or confusion may matter more than a modest change in a symptom score if they compromise walking or independent living. Prescription and nonprescription medicines both belong in an interaction review. Alcohol and other sedating substances can complicate the picture. CBD should also be included in the discussion rather than assumed to be medically inactive.
What useful follow-up measures
A care discussion should identify a concrete symptom and observe function, adverse effects and the person’s own priorities. Family involvement can help when the patient wants it, while preserving autonomy and consent. Claims of universally better mobility, mood or safety are too broad; the appropriate standard is a monitored, individualized assessment rather than replacing established care on the basis of a testimonial.
Sources & further reading
General information, not individual legal or medical advice.